This content requires a premium subscription.
Please log in or subscribe to continue.
JACC Specialty Journals
JACC: Clinical Electrophysiology - Impact of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Recurrence of Atrial Fibrillation after Catheter Ablation in Patients with Type-2 Diabetes
Released: Aug 9, 2023
Commentary by Dr. Emile Daoud
JACC: Clinical Electrophysiology - Impact of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Recurrence of Atrial Fibrillation after Catheter Ablation in Patients with Type-2 Diabetes
